GlassScriptPhysician profile
Amy Beth Pedone
NPI 1417940693
$859.58
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $273 · 2021: $256 · 2022: $54.44.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $198.61 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $111.97 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $86.70 | 2019-2022 | |
| Abbvie INC. | $80.90 | 2021-2022 | |
| Novo Nordisk INC | $76.70 | 2020-2022 | |
| Allergan, INC. | $70.55 | 2020 | |
| Amarin Pharma, INC. | $59.23 | 2020-2021 | |
| Astellas Pharma US INC | $51.18 | 2019 | |
| Jazz Pharmaceuticals INC. | $41.84 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $35.13 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.03 | 2021 | |
| Sanofi Pasteur INC. | $15.60 | 2021 | |
| Bausch Health US, LLC | $14.14 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Pedone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.